期刊文献+

连续性血液滤过治疗脓毒性休克36例临床评价

Clinical Efficacy of Continuous Veno-venous Hemofiltration in Treatment of Septic Shock
下载PDF
导出
摘要 目的:探讨连续性静脉-静脉血液滤过(CVVH)治疗脓毒性休克的临床疗效。方法:本院综合ICU病房67例脓毒性休克患者分为对照组和治疗组,前者31例常规应用液体复苏、血管活性药物、联合抗感染等治疗,后者36例在常规治疗基础上加CVVH治疗。比较两组患者治疗前后呼吸频率(RR)、心率(HR)、中心静脉压(CVP)、平均动脉压(MAP)、动脉血氧饱和度(SaO_2)、APACHE Ⅱ评分、血尿素氮(BUN)、血肌酐(Cr)、氧合指数(PaO_2/FiO_2)、血乳酸水平和ICU病死率的变化。结果:治疗组的RR、HR、MAP、APACHE Ⅱ评分、BUN、Cr、PaO_2/FiO_2、血乳酸水平和ICU病死率与对照组比较均有显著差异(P<0.05)。结论:在常规治疗的基础上加用CVVH治疗脓毒性休克能有效改善患者的血流动力学,维持内环境稳定,改善组织缺氧,降低病死率。 Objective:To investigate the clinical effects of continuous veno-venous hemofihration (CVVH) in treatment of septic shock. Method:67 patients with septic shock in the intensive care unit (ICU) were divided into either the treatment group(n=36) or the control group(n=31 ). The control group was received routine therapy methods consist of fluid resuscitation, vasoactive agent, combine anti-infection etc. The treatment group was received the same therapy methods besides CVVH. The respiratory frequency (RR), heart rate (HR), central venous pressure(CVP), mean arterial pressure (MAP), arterial oxygen saturation(SaO2), APACHE Ⅱ scores, blood urea nitrogen (BUN), serum creatinine(Cr), oxygenation index(PaOJFiO2), arterial blood lactic acid and mortality were assessed between treatment group and control group. Results:There were significant differences for the RR, HR, MAP, APACHE Ⅱ scores, BUN, serum Cr, PaO2/FiO2, arterial blood lactic acid and mortality between treatment group and control group (P〈0.05). Conclusion: CVVH therepy could protect the patients with septic shock effectively through improving haemodynamies and tissue hypoxia, sustaining homeostasis and decreasing mortality.
出处 《岭南急诊医学杂志》 2010年第2期73-75,共3页 Lingnan Journal of Emergency Medicine
关键词 连续性血液滤过 连续性血液净化 脓毒性休克 continuous veno-venous hemofihration continuous blood purification septic shock
  • 相关文献

参考文献7

  • 1Vincent JL,Abraham E,Annane D,et al.Reducing mortality in sepsis:New directions.Crit care,2002,6(supl3):S1.
  • 2Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med,2003,31(4):1250.
  • 3Marshall JC,Cook DJ,Christou NV,et al.Multiple organ dysfunction score:A reliable descriptor of a complex clinical outcome.Crit Care Med,1995,23(6):1638.
  • 4Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care.Crit Care Med,2001,29(7):1303.
  • 5Dellinger RP,Levy MM,Cadet JM,et al.Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock:2008.Crit Care Med,2008,36(1):296.Erratum in:Crit Care Med,2008,36(4):1394.
  • 6Matsumoto K,Hayashi T.Continuous venovenous hemofiltration(CVVH)therapy in patient with refractory heart failure.Nippon Rinsho,2007,28(5):255.
  • 7王晏平,邹作君,王旭,邵一兵,王正忠.连续性血液滤过对老年性瓣膜病并发顽固性心力衰竭的治疗作用[J].中国血液净化,2005,4(3):154-156. 被引量:11

二级参考文献7

  • 1乔健华,杨桂英,王勇,佟力.人工肾透析在抢救重危心内直视术后患者中的临床应用[J].中国循环杂志,1994,9(10):599-600. 被引量:4
  • 2Flather MD, Yusug S, Kober L, et al. Long- term ACE- inhibitor therapy in patients with heart failure or left - ventricular dysfunction: a systematic overview of data from individual patients. ACE - Inhibitor Myocardial Infarction Collaborative Group. Lancet, 2000,355:1575- 1581
  • 3Bergerone S, Golzio PG, Pacitti A. Atrial natriuretic factor and concomitant hormonal,hemodynamic and renal function changes after slow continous ultrafiltration. Intern J Cardiol, 1992,36 (3): 305 - 307
  • 4Ma KW, Greene EI, Raij L. Cardiovascular risk factor in chronic renal failure and hemodialysis populations. Am J Kidney, 1992,19(6) :505 -513
  • 5Robert OB. Maragement of cardiovascular - renal complication. Circulation, 2002,105:e159 - e164
  • 6Inove T, Sakal Y, Morooka S. Hemofiltration as treatment for patients with refractory heart failure. Clin cardiol, 1992,15(7) :514 - 518
  • 7Rimondin A, Cipolla CM, Bella PD, et al. Hemofiltration as short - term treatment for refractory congestive heart failure. Am J Med, 1987,83:43-48

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部